Literature DB >> 20394979

Interactions between innate and adaptive immunity in asthma pathogenesis: new perspectives from studies on acute exacerbations.

Patrick G Holt1, Deborah H Strickland.   

Abstract

Asthma is a complex multigenic disease. The most frequently encountered form is atopic asthma, which is at its highest prevalence during childhood/young adulthood, and this represents the main focus of this review. The primary risk factor for atopic asthma is sensitization to perennial aeroallergens resulting from a failure to generate protective immunologic tolerance. This tolerance process is orchestrated by airway mucosal dendritic cells and normally results in programming of regulatory T cells, which inhibit activation of the T(H)2 memory cells that, among other activities, drive IgE production and prime the effector populations responsible for IgE-mediated tissue damage. Emerging evidence highlights the complexity of this process, in particular the iterative nature of the underlying interactions between innate and adaptive immune mechanisms in which virtually every signal emanating from one cellular compartment provokes an answering response from the other. To further complicate this picture, the local mesenchyme can also interpose signals to fine tune immune responses to optimally meet local microenvironmental needs. Perturbation of the balance between these interlinked innate and adaptive immune pathways is increasingly believed to be the basis for disease expression, and in the specific case of atopic asthma, the prototypic example of this (discussed below) is acute exacerbations triggered by viral infections. Copyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20394979     DOI: 10.1016/j.jaci.2010.02.011

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  33 in total

1.  Thymic stromal lymphopoietin amplifies the differentiation of alternatively activated macrophages.

Authors:  Hongwei Han; Mark B Headley; Whitney Xu; Michael R Comeau; Baohua Zhou; Steven F Ziegler
Journal:  J Immunol       Date:  2012-12-28       Impact factor: 5.422

2.  Unbiased screening of marine sponge extracts for anti-inflammatory agents combined with chemical genomics identifies girolline as an inhibitor of protein synthesis.

Authors:  Shan-Yu Fung; Vladimir Sofiyev; Julia Schneiderman; Aaron F Hirschfeld; Rachel E Victor; Kate Woods; Jeff S Piotrowski; Raamesh Deshpande; Sheena C Li; Nicole J de Voogd; Chad L Myers; Charlie Boone; Raymond J Andersen; Stuart E Turvey
Journal:  ACS Chem Biol       Date:  2013-10-29       Impact factor: 5.100

Review 3.  Respiratory viral infection, epithelial cytokines, and innate lymphoid cells in asthma exacerbations.

Authors:  Rakesh K Kumar; Paul S Foster; Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2014-06-05       Impact factor: 4.962

Review 4.  Advances in pediatric asthma in 2010: addressing the major issues.

Authors:  Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2011-01       Impact factor: 10.793

5.  Single-cell transcriptomic analysis reveals the immune landscape of lung in steroid-resistant asthma exacerbation.

Authors:  Lingli Wang; Keilah G Netto; Lujia Zhou; Xiaojie Liu; Ming Wang; Guojun Zhang; Paul S Foster; Fuguang Li; Ming Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-12       Impact factor: 11.205

6.  Vitamin d levels in children with bronchial asthma.

Authors:  A R Somashekar; Ashwini B Prithvi; M N Vanitha Gowda
Journal:  J Clin Diagn Res       Date:  2014-10-20

Review 7.  Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.

Authors:  Merouane Bencherif; Patrick M Lippiello; Rudolf Lucas; Mario B Marrero
Journal:  Cell Mol Life Sci       Date:  2010-10-15       Impact factor: 9.261

Review 8.  The pharmacological modulation of allergen-induced asthma.

Authors:  L L Ma; Paul M O'Byrne
Journal:  Inflammopharmacology       Date:  2012-10-25       Impact factor: 4.473

9.  Lung function and biomarkers of airway inflammation during and after hospitalization for acute exacerbations of childhood asthma associated with viral respiratory symptoms.

Authors:  Jason S Debley; Elizabeth S Cochrane; Gregory J Redding; Edward R Carter
Journal:  Ann Allergy Asthma Immunol       Date:  2012-06-26       Impact factor: 6.347

10.  Selective Antagonists of the Bronchiolar Epithelial NF-κB-Bromodomain-Containing Protein 4 Pathway in Viral-Induced Airway Inflammation.

Authors:  Bing Tian; Zhiqing Liu; Jun Yang; Hong Sun; Yingxin Zhao; Maki Wakamiya; Haiying Chen; Erik Rytting; Jia Zhou; Allan R Brasier
Journal:  Cell Rep       Date:  2018-04-24       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.